UK’s patent incentive leads to GSK investment
GlaxoSmithKline will invest more than £500 million in the UK, after the government confirmed it would provide a tax incentive for patents
GSK said it would manufacture a new respiratory device at a facility at Ware in Hertfordshire, and set up a £50 million ($78 million) UK venture capital fund.
That followed chancellor George Osborne's confirmation that he would back the previous...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.